SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LoLoLoLita who wrote (4622)1/15/1998 7:07:00 PM
From: bigg e  Read Replies (1) of 23519
 
Dave...It sounds like Q1 estimates will be tough to call regardless of MCA approval or not. Between marketing campaign expeditures, no clear definition of european product margins, no info as to current or estimated production capability at new facility and no info as to "at risk" product currently in inventory it's hard to say what the numbers could be. Hopefully the VVUS IR phone line was very busy post CC with analysts calls addressing some of these issues. Long term they seem to be on track. Short term , I think there are too many unknowns for any analysts upgrades or major uptrends in the stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News